West Pharmaceutical Services, Inc. (WST)

Market Cap	23.05B
Revenue (ttm)	2.88B
Net Income (ttm)	499.60M
Shares Out	72.42M
EPS (ttm)	6.74
PE Ratio	47.14
Forward PE	44.52
Dividend	$0.84 (0.26%)
Ex-Dividend Date	Nov 13, 2024

Volume	87,631
Open	320.60
Previous Close	322.65
Day's Range	316.20 - 324.27
52-Week Range	265.00 - 413.70
Beta	1.01
Analysts	Buy
Price Target	460.33 (+44.63%)
Earnings Date	Oct 24, 2024

About WST

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhanc...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1923
• Employees: 10,600
• Stock Exchange: NYSE
• Ticker Symbol: WST
• Website: https://www.westpharma.com

Financial Performance

In 2023, WST's revenue was $2.95 billion, an increase of 2.18% compared to the previous year's $2.89 billion. Earnings were $593.40 million, an increase of 1.28%.

Analyst Forecast

According to 3 analysts, the average rating for WST stock is "Buy." The 12-month stock price forecast is $460.33, which is an increase of 44.63% from the latest price.

Price Target

$460.33

(44.63% upside)

Analyst Consensus: Buy